COMPASS THERAPEUTICS INC (CMPX)

US20454B1044 - Common Stock

1.38  +0.01 (+0.73%)

After market: 1.38 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/A
610.48%
N/A
1,026.59%
N/A
173.44%
N/A
95.88%
N/A
46.18%
N/A
34.39%
N/A
11.63%
EBITDA
YoY % growth
-36.39M-31.93M
12.26%
-25.41M
20.42%
-81.31M
-219.99%
-40.88M
49.72%
-49.664M
-21.49%
N/A
-26.51%
N/A
-6.82%
N/A
8.21%
N/A
42.32%
N/A
324.28%
N/A
104.30%
N/A
58.98%
N/A
EBIT
YoY % growth
-38.31M-34.05M
11.12%
-27.81M
18.33%
-81.88M
-194.43%
-41.66M
49.12%
-50.363M
-20.89%
N/A
-11.49%
N/A
-26.51%
N/A
-4.66%
N/A
105.11%
N/A
4,056.88%
N/A
65.97%
N/A
54.48%
N/A
47.17%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/A-0.37
69.70%
-0.34
8.11%
N/A
-5.86%
N/A
-21.09%
N/A
-1.97%
N/A
141.77%
N/A
343.96%
N/A
71.41%
N/A
48.01%
N/A
39.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.10
8.47%
-0.08
-6.25%
-0.09
13.30%
-0.09
-10.50%
-0.09
6.80%
Revenue
Q2Q % growth

-100.00%
EBITDA
Q2Q % growth
-14.204M
3.34%
-12.73M
-0.90%
-13.219M
10.31%
-14.688M
-24.58%
-15.055M
-6.00%
EBIT
Q2Q % growth
-15.066M
2.13%
-14.236M
-11.48%
-15.26M
-1.43%
-16.423M
-34.19%
-17.056M
-13.21%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.08 -0.120.0430.79%
Q2 2024
Q2Q % growth
-0.10
-11.11%
-0.100.00-3.20%
Q1 2024
Q2Q % growth
-0.08
-33.33%
-0.120.0430.51%
Q4 2023
Q2Q % growth
-0.11
-10.00%
-0.10-0.01-14.56%
Q3 2023
Q2Q % growth
-0.08
33.33%
-0.110.0326.80%
Q2 2023
Q2Q % growth
-0.09
-12.50%
-0.08-0.01-8.36%
Q1 2023
Q2Q % growth
-0.06
14.29%
-0.110.0545.82%
Q4 2022
Q2Q % growth
-0.10
52.38%
-0.110.0112.85%
Q3 2022
Q2Q % growth
-0.12
-20.00%
-0.11-0.01-10.29%
Q2 2022
Q2Q % growth
-0.08 -0.090.016.95%
Q1 2022
Q2Q % growth
-0.07 -0.110.0437.61%
Q4 2021
Q2Q % growth
-0.21 -0.07-0.14-182.57%
Q3 2021
Q2Q % growth
-0.10 -0.130.0321.57%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 19.66% 16.32% 16.32%
RevenueN/A N/A -0.57% 23.24%